Patent ID: 11897932
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The chimeric polypeptide of claim 1, wherein the ligand is selected from the group consisting of CD19, CD59, CD66, CD73, CD80 (B7.1), CD86 (B7.2), CD94, CD134, CD140 (PDGFR4), CD152, CD154, CD158, CD178, CD181 (CXCR1), CD182 (CXCR2), CD183 (CXCR3), CD246, CD273 (PD-L2), CD274 (PD-L1), CD295, CD340 (HER2), FGFR2, CEA, AFP, CA125, MUC-1, MAGE, alkaline phosphatase, placental-like 2 (ALPPL2), green fluorescent protein (GFP), enhanced green fluorescent Protein (eGFP), and signal regulatory protein α (SIRPα).